Lupin Q2 FY26: revenue up 24%, PAT boosted by divestment gain

Revenue Growth 20pctExceptional ItemResults View source PDF Explain this filing

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹1970.00

prior close

₹1984.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.5%-0.5% vs market

Pharmaceuticals peers, median of 156sector-0.0%-0.0% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Midcap 150 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.3

15m

-0.0

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+0.5-0.5-0.0-0.0

Next day

+0.8+0.9-0.2-0.7+1.4

+0.5+1.4-0.9-1.0+1.5

+3.5+2.1+1.3+0.1+3.4

+4.4+1.8+2.5+0.2+4.2

+4.3+1.9+2.4-0.0+4.3

+4.1+1.9+2.1-0.3+4.4

15d

+5.6+2.2+3.5-1.7+7.3

+5.0-0.4+5.5-5.4+10.4

+12.4+3.1+9.3-2.9+15.3

+12.1+1.6+10.5-7.4+19.5

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated Q2 revenue grew 24% year on year to Rs 70,475 million. PAT jumped 73% to Rs 14,848 million, lifted by Rs 5,927 million exceptional gain from transferring its OTC and API R&D business in India to wholly owned subsidiaries. H1 revenue rose 18% to Rs 133,159 million. Signed deal to acquire Netherlands-based VISUfarma for Euro 190 million. Paid Rs 12 per share final dividend in August. BSR and Co LLP issued a clean limited review report.

Likely market impact

Strong revenue growth and one-time divestment gain lifted Q2 earnings. Watch margin trends excluding exceptional items and impact of new acquisitions.